Global efforts in the fight against COVID-19
Innovation-led NGS solutions and integrated bioinformaticsGain greater insights into the epidemiology of SARS-CoV-2 with a full spectrum of NGS solutions and integrated bioinformatics pipelines.
Understanding the impact on test resultsStay up to date on our continuous surveillance assessing the impact of mutations on assay sensitivity. (Updated April 2021)
Latest – new solutions, webinars and updates
Discover a 50% faster, high-throughput SARS-CoV-2 NGS solutionAccelerate SARS-CoV-2 genomic surveillance and develop an accurate picture of circulating variants with ultrafast whole viral genome sequencing using QIAseq DIRECT SARS-CoV-2 Kits.
QIAGEN adds kits for wastewater testing to COVID-19 portfolioQIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing.
QIAGEN launches artus Prep&Amp as CE-marked SARS-CoV-2 TestThe artus Prep&Amp test offers up to threefold increase in daily lab testing capacity.
QIAGEN launches SARS-CoV-2 test for T cell responseQIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of COVID-19 through T cell response
How can we support your lab?
Reach a specialist about SARS-CoV-2 resources.